High Frequency Peripheral nerve stimulation for chronic pain

High frequency (HF10) peripheral nerve stimulation (PNS) for chronic neuropathic pain

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12616000971437

Acronym

HF10 PNS

Enrollment

Registered

2016-07-25

Start date

2016-08-15

Completion date

2017-10-09

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study is a clinical audit of patients undergoing implantation of a commercially-available and TGA-approved high frequency stimulator (TGA certificate DV-2011-MC-00182-3) between 1st January 2013 and 1st February 2017 for the clinical management of pain. The study will be a two-year audit of pain scores, disability index, analgesic drug consumption and patient satisfaction after implantation of a high frequency electrical nerve stimulator. Each patient will provide their informed consent for their data to be included in the clinical audit.

Interventions

This study is a clinical audit of patients undergoing implantation of commercially-available and TGA-approved high frequency stimulators (Nevro high frequency stimulator and electrode leads, TGA certificate DV-2011-MC-00182-3) in the clinical management of pain. Pain ratings, Oswestry Disability ratings, patient satisfaction and morphine equivalent consumption will be assessed before the implant and one year aferwards.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

All patients at Dr Finch’s pain practice who were implanted with a high frequency electrical nerve stimulator (Nevro high frequency stimulator and electrode leads, TGA certificate DV-2011-MC-00182-3) between 1st January 2013 and 1st February 2017 will be invited to be included in the clinical audit.

Exclusion criteria

None

Outcome results